Chronic Postoperative Endophthalmitis Caused by Actinomyces meyeriPeponis V.G. · Chalkiadakis S.E. · Parikakis E.A. · Mitropoulos P.G.
‘Ophthalmiatreio’ Athens Eye Hospital, Second Eye Clinic, Athens, Greece
Vasileios G. Peponis, MD, MSc, PhD
‘Ophthalmiatreio’ Athens Eye Hospital, Second Eye Clinic
Eleftheriou Venizelou 26, GR–10672 Athens (Greece)
Tel. +30 210 362 3191, E-Mail email@example.com
Do you have an account?
We report a female patient who developed chronic endophthalmitis after an uneventful cataract surgery. Cultures of aqueous humor and a vitreous sample showed positivity for Actinomyces meyeri. Intense anterior segment inflammation and a less evident impairment of the patient’s posterior segment led us to treat her vigorously with pars plana vitrectomy combined with intraocular and topical antibiotics. The patient achieved a good recovery of vision without the need to remove the intraocular lens and to add systemic drugs. To the best of our knowledge, this is the first reported case of an intraocular infection caused by A. meyeri after small-incision clear corneal phacoemulsification.
© 2011 S. Karger AG, Basel
Article / Publication Details
Open Access License / Drug Dosage / DisclaimerOpen Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.